If you need any product or service please register as the Farmavita.Net network member and publish your needs.
License-in is very cost effective way of product development. In the most of the licensing cases you will pay only share of total development cost for the pharmaceutical product.
Published license-out opportunities are alphabetically listed according to pharmaceutical INN name.
Please choose the category below:
Offer for CDT dossier
PopularDescription
CDT dossier
Joint-stock company Aconitum develops, manufactures and markets RX and OTC medicines, homeopatic medicines and food supplements. All the products are manufactured by the company “Aconitum” following the European Good Manufacturing Practice (GMP) standards applied for medicinal products. In production of nutraceuticals “Aconitum” applies requirements of the HACCP. Following this system the health safety of the products is granded.
Joint-stock company Aconitum develops, manufactures and markets RX and OTC medicines, homeopatic medicines and food supplements. All the products are manufactured by the company “Aconitum” following the European Good Manufacturing Practice (GMP) standards applied for medicinal products. In production of nutraceuticals “Aconitum” applies requirements of the HACCP. Following this system the health safety of the products is granded.
Joint-stock company Aconitum can offer CDT dossiers:
Vinpocetine 5mg, 10 mg
5-HTP (Griffonia simplicifolia) 150 mg
Glucosamine 750 mg
Milk thistle (Silybum marianum) 140 mg
Ginkgo (Ginkgo biloba) 80 mg
Bilberry (Vaccinium myrtillus) 160 mg
Horse chestnut (Aesculus hippocastanum) 250 mg
Gytautas Cvirka
Export manager
UAB "Aconitum"
Innovation street. 4, Kaunas
Lithuania
Tel. (8-37) 328008
Faks. (8-37) 338487
Tel. 8 614 45055
gytautas@aconitum.lt
skype: aconitum
web: www.aconitum.lt
Export manager
UAB "Aconitum"
Innovation street. 4, Kaunas
Lithuania
Tel. (8-37) 328008
Faks. (8-37) 338487
Tel. 8 614 45055
gytautas@aconitum.lt
skype: aconitum
web: www.aconitum.lt
More details
| Name | Description |
|---|---|
| Pharma licensing | Out-licensing (offer) |
